CHI Immuno-Oncology Summit

October 4-5, 2021, Westin Copley Place, Boston, MA

Visit us at Booth # 9

Talk: Monday, October 04, 2021, 12:10 pm to 12:45 pm – Track: Predicting Clinical Outcome

Immunophenotyping of TCR and BCR clonotypes

TCR/BCR repertoire profiling holds great potential for understanding disease mechanisms. We introduce a novel technology for profiling of all human TCR and BCR variable regions and phenotypic characterization of immune cells in bulk and at the single-cell level in PBMCs and immune cell fractions. Preliminary data shows that TCR/BCR clonotype analysis combined with targeted expression profiling of immune cells can be applied for large-scale discovery in several immune-responsive model systems. 

Presenter: Alex Chenchik, PhD, President and Chief Scientific Officer, Cellecta

View Event
Please email info@cellecta.com with any comments.


Also in Events, Conferences, Meetings

FOCIS 2024 Annual Meeting

June 18-21, 2024
Read More
AIRR Community Meeting

June 3-6, 2024
Read More
Immunology2024 Conference

May 3-7, 2024
Read More